241029 endosemio
EndoSemio Co., Ltd.
apartment National Taiwan University
Highlight
location_on Rm. 102, 1F, No. 8, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu, 302058, Taiwan
Founded Date :
calendar_month 2023/06/29
Funding Round :
paid Pre-A
Total fundraising amount :
2,000,000 USD
Number of Employees :
group 1~30
Industries :
category Biotechnology, Healthcare
Contact
241031 ppl1 2
name of CEO :
account_circle William (Ting-Hsuan) Chen
Contact Person Name :
contact_phone Ruby Hung
Contact Person Title :
subtitles Chief Marketing Officer
Contact Person Phone :
call 03-6675508
Contact Email :
mail Email
Recent News
no recent news
About clarify

EndoSemio is an innovative company that originated from the National Taiwan University College of Medicine and is sponsored by the government. We are pioneers in the development of single-use endoscopes tailored for healthcare professionals. We actively listen to clinicians, and our products are crafted to meet their specific needs. Our expertise seamlessly combines hardware and software in innovative tools, such as wireless endoscope imaging tracheostomy kits, neonatal and pediatric respiratory imaging catheters, and single-use flexible ureteroscopes. We are dedicated to reshaping healthcare with safer and more efficient tools, setting a new global standard in medical innovation.
EndoSemio mainly targets the design and manufacturer of high-end disposable/single-use endoscopy for minimally invasive surgeries and has established a complete quality system with solid medical design experience. Combined with rapid trial production, rapid introduction, and clinical verification, it has become a leading manufacturer of disposable/single-use high-end imaging plus minimally invasive medical materials design and manufacturer.

Technology experiment

EndoSemio’s unwavering focus is on the research and development, as well as the manufacturing, of miniaturized endoscopes designed for single-use applications, complemented by high biocompatibility tubing materials. Guided by the demands of clinical practitioners, our development process is grounded in a commitment to meeting their precise requirements. Simultaneously, we possess a distinctive proficiency in harmoniously merging the intricate aspects of imaging modules, effectively encapsulating both software and hardware elements into a cohesive whole.

  • Imaging Miniaturization & Manufacturing Process: Lower cost with CMOS Sensors and higher quality of our images.
  • User-Driven – Based on Clinical Need: All products are conceived by clinicians, 100% meet clinical needs, and have been endorsed by more than 20 physicians from various institutions.
  • Software-to-Hardware integration platform: Our technology can connect with the mobile with our wireless technology and guiding the endoscopy with our VR technology.
  • Clinical Interface and Process: Our innovative medical device is designed according to the original gold practice. There is no steep learning curve.
Products deployed_code

EndoSemio focuses on the R&D of innovative endoscopic products by using miniaturized technology to create endoscopes that meet various clinical needs, providing patients with full protection and enabling doctors to deliver more precise diagnoses and treatments.

  • Innovative Wireless Endoscope Imaging Tracheostomy kit: First in the world provide the direct image in the front of tracheostomy tube which avoid the complications and improves the procedure with better efficiency and patient safety.
  • Neonatal Intubation Image Guiding System: In neonatal care, precision is paramount, our image guiding system enables clinicians to navigate delicate airways with confidence, ensuring successful intubations and minimizing trauma for our tiniest patients.
  • Ureteroscope: Our ureteroscope offers enhanced visualization through miniaturized imaging modules and advanced inserted tube materials. By reducing the risk of infections and cross-contamination, we elevate the standard of care for patients and healthcare providers.
Marketing linked_services
  • As more minimally invasive surgeries adopt endoscope technology, the demand for single-use endoscopes is rapidly growing. This shift reflects a global trend towards safer and more efficient procedures. According to market research, the global market for single-use endoscopes was valued at USD 1.35 billion in 2020 and is projected to reach USD 6.29 billion by 2028, with a compound annual growth rate (CAGR) of 21.1%. This presents a substantial opportunity for EndoSemio to capture a significant market share as healthcare providers increasingly prioritize disposable solutions to minimize cross-contamination risks and improve patient safety.
  • Our value proposition is centered on meeting critical unmet clinical needs. EndoSemio’s single-use endoscopes not only enhance procedural safety but also improve patient throughput in hospitals. By reducing the risk of infection and offering high-quality, disposable alternatives to reusable endoscopes, we enable more efficient operations. This directly benefits patients, healthcare providers, and hospital systems by reducing costs and improving clinical outcomes.
  • For our go-to-market strategy, EndoSemio will follow a structured approach, beginning with clinical validation and expanding into B2B distribution through established medical technology distributors. We have already signed several Memorandums of Understanding (MOUs) with key distributors to facilitate our market entry and ensure strong distribution channels, further supporting our ability to capture market share quickly.

As minimally invasive surgeries continue to grow in popularity and disposable endoscope technology becomes the standard, EndoSemio is well-positioned to lead in this fast-expanding market.

Video smart_display
Award trophy
  1. trophy 2024 BioAsia Best Popularity Award, the global Biotechnology Innovation Organization (BIO)
  2. trophy 2024, SelectUSA Startups Health Tech Winner, U.S. Department of Commerce
  3. trophy 2023 InnoAward, Research Center for Biotechnology and Medicine Policy